External publications
2013
Brunetti, M., I. Shemilt, S. Pregno, L. Vale, A. Oxman, J. Lord, J. Sisk, F. Ruiz, S. Hill, G. Guyatt, R. Jaeschke, M. Helfand, R. Harbour, M. Davoli, L. Amato, A. Liberati, and H. Schünemann. 2013. “GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence.” Journal of Clinical Epidemiology 66(2): 140-50.
Donovan, C. 2013. “Beyond the 'Postmodern University'.” The European Legacy: toward new paradigms 18(1): 24-41.
Dretzke, J., A. Meadows, N. Novielli, A. Huissoon, A. Fry-Smith, and C. Meads. 2013. “Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: A systematic review and indirect comparison.” J Allergy Clin Immunol.
Dritsaki, M. and C. Dritsaki. 2013. “The Bound Testing Approach for Cointegration and Causality between Financial Development, Trade Openness and Economic Growth in Bulgaria.” The IUP Journal of Applied Economics XII(1): 50-67.
Longworth, L. and D. Rowen. 2013. “Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments.” Value in Health 16: 202-10.
Longworth, L., J. Youn, L. Bojke, S. Palmer, S. Griffin, E. Spackman, and K. Claxton. 2013. “When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?” PharmacoEconomics.
Meads, C., P. Auguste, C. Davenport, S. Małysiak, S. Sundar, M. Kowalska, A. Zapalska, P. Guest, S. Thangaratinam, P. Martin-Hirsch, E. Borowiack, P. Barton, T. Roberts, and K. Khan. 2013. “Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.” Health Technol Assess 17(12): 1-323.
Meads, C., P. Auguste, C. Davenport, S. Małysiak, S. Sundar, M. Kowalska, A. Zapalska, P. Guest, S. Thangaratinam, P. Martin-Hirsch, E. Borowiack, P. Barton, T. Roberts, and K. S. Khan. 2013. “PET-CT imaging in detecting and managing recurrent cervical cancer: Systematic review of evidence, elicitation of subjective probabilities and economic modelling.” Health Technology Assessment.
Morris, R. K., E. A. Oliver, G. Malin, K. S. Khan, and C. Meads. 2013. “Effectiveness of interventions for the prevention of small-for-gestational age fetuses and perinatal mortality: a review of systematic reviews.” Acta Obstet Gynecol Scand 92(2): 143-51.
Mulhern, B., L. Longworth, J. Brazier, D. Rowen, N. Bansback, N. Devlin, and A. Tsuchiya. 2013. “Binary Choice Health State Valuation and Mode of Administration: Head-to-Head Comparison of Online and CAPI.” Value in Health 16(1): 104-13.
Pokhrel, S. 2013. “Pooling anti-tobacco expertise.” International Innovation. pp. 46-48.
Tirlapur, S. A., K. Kuhrt, C. Chaliha, E. Ball, C. Meads, and K. S. Khan. 2013. “The 'evil twin syndrome' in chronic pelvic pain: A systematic review of prevalence studies of bladder pain syndrome and endometriosis.” International Journal of Surgery 11(3): 233-37.
Trapero-Bertran, M., H. Mistry, J. Shen, and J. Fox-Rushby. 2013. “A systematic review and meta-analysis of WTP values: the case of malaria control interventions.” Health Economics 22(4): 428-50.
Yang, Y., J. Brazier, and A. Tsuchiya. 2013. “The effect of adding a ‘sleep’ dimension to the EQ-5D descriptive system.” Medical Decision Making.
2012
Anokye, N. K., S. Pokhrel, M. Buxton, and J. Fox-Rushby. 2012. “Physical activity in England: who is meeting the recommended level of participation through sports and exercise?” The European Journal of Public Health. Download publication
Adams, J., C. Bridle, S. Dosanjh, P. Heine, S. Lamb, J. Lord, C. McConkey, V. Nichols, F. Toye, M. Underwood, M. Williams, and E. Williamson. 2012. “Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): Design of a randomised controlled trial of a hand and upper limb exercise intervention - ISRCTN89936343.” BMC Musculoskeletal Disorders 13(230). Download publication
Brazier, J., D. Rowen, I. Mavranezouli, A. Tsuchiya, T. Young, Y. Yang, M. Bakhram, and R. Ibbostson. 2012. “Developing and testing methods for deriving preference-based measures of health from condition specific measures (and other patient based measures of outcome).” Health Technology Assessment 16(32): 1-114. Download publication
Claxton, K., S. Palmer, L. Longworth, L. Bojke, S. Griffin, C. McKenna, M. Soares, E. Spackman, and J. H. Youn. 2012. “Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.” Health Technology Assessment 16(46). Download publication
Dritsaki, C. and M. Dritsaki. 2012. “Exports and FDI: A Granger causality analysis in a heterogeneous panel.” Economics Bulletin 32(4): 3128-39. Download publication
Dritsaki, M. and C. Dritsaki. 2012. “The stability of Money Demand: Evidence from Turkey.” The IUP Journal of Bank Management XI(4): 1-22.
Renfrew, M. J., S. Pokhrel, M. Quigley, F. McCormick, J. Fox-Rushby, R. Dodds, S. Duffy, P. Trueman, and A. Williams. 2012. “Preventing disease and saving resources: the potential contribution of increasing breastfeeding rates in the UK.” UNICEF UK. Download publication
Sauzet, O., J. L. Peacock, J. E. Williams, J. Ross, R. Branford, P. Farquhar-Smith, G. L. Griffith, and J. A. Fox-Rushby. 2012. “The characteristics and quality of randomized controlled trials in neuropathic pain: a descriptive study based on a systematic review.” The Clinical Journal of Pain.
Trueman, P. and N. Anokye. 2012. “Applying economic evaluation to public health interventions: the case of interventions to promote physical activity.” Journal of Public Health. Download publication
Ling T, Soper B, Watt A, Steel N, Buxton M, Hanney S, Disley E. (2012) Involving Primary Care Clinicians in Quality Improvement: An Independent evaluation of the Engaging with Quality in Primary Care programme. London: The Health Foundation. Download publication
Singh, J., Lord, J., Longworth, L., Orr, S., McGarry, T., Sheldon, R. and Buxton, M., Does Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care Safety., Value Health (2012) 15 (5) : 690- 698 Download publication
Youn, J.H., Lord, J., Hemming, K., Girling, A., and Buxton, M., Bayesian meta-analysis on medical devices: Application to implantable cardioverter defibrillators. International Journal of Technology Assessment in Health Care, 2012. 28(2): p. 115-124. Download publication
Vogl, M., Wenig, C.M., Leidl, R., and Pokhrel, S., Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health, 2012. 12(203). Download publication
Trapero-Bertran, M., Mistry, H., Shen, J., and Fox-Rushby, J., A systematic review and meta-analysis of WTP values: the case of malaria control interventions. Health Economics, 2012. Download publication
Tosh, J., Brazier, J., Evans, P., and Longworth, L., A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders. Value in Health, 2012. 15(1): p. 118-127. Download publication
Sharples, L.D., Jackson, C., Wheaton, E., Griffith, G., Annema, J.T., Dooms, C., Tournoy, K.G., Deschepper, E., Hughes, V., Magee, L., Buxton, M., and Rintoul, R.C., Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: Results from the ASTER randomised controlled trial. Health Technology Assessment, 2012. 16(18): p. 1-81. Download publication
Lin, F.J., Longworth, L., and Pickard, A.S., Evaluation of content on EQ-5D as compared to disease-specific utility measures. Quality of Life Research, 2012: p. 1-22. Download publication
Jones, T.H., Donovan, C., and Hanney, S., Tracing the wider impacts of biomedical research: a literature search to develop a novel citation categorisation technique. Scientometrics, 2012: p. 1-10. Download publication
Dritsaki, M. and Dritsaki, C., A panel data approach to the demand for money in Bulgaria and Romania. Applied Economics Letters, 2012. 19(8): p. 705-710.
Chambers, J.D., Morris, S., Neumann, P.J., and Buxton, M.J., Factors Predicting Medicare National Coverage An Empirical Analysis. Medical Care, 2012. 50(3): p. 249-256. Download publication
2011
Young, T.A., Yang, Y., Brazier, J.E., and Tsuchiya, A., The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: The case of moving from AQLQ to AQL-5D. Medical Decision Making, 2011. 31(1): p. 195-210.
Yang, Y., Brazier, J.E., Tsuchiya, A., and Young, T.A., Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire. Medical Decision Making, 2011. 31(2): p. 281-291.
Wooding, S., Hanney, S., Pollitt, A., Buxton, M., and Grant, J., Project Retrosight: Understanding the returns from cardiovascular and stroke research: The Policy Report. 2011: Santa Monica, CA. http://www.rand.org/pubs/monographs/MG1079.html
Whitehead, S.J., Forest-Bendien, V.L., Richard, J.L., Halimi, S., Ha Van, G., and Trueman, P., Economic evaluation of Vacuum Assisted Closure® Therapy for the treatment of diabetic foot ulcers in France. International Wound Journal, 2011. 8(1): p. 22-32.
Vallejo-Torres, L., Steuten, L., Parkinson, B., Girling, A.J., and Buxton, M.J., Integrating health economics into the product development cycle: A case study of absorbable pins for treating hallux valgus. Medical Decision Making, 2011. 31(4): p. 596-610.
Tosh, J.C., Longworth, L.J., and George, E., Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals. Value in Health, 2011. 14(1): p. 102-109.
Reidpath, D.D., Allotey, P., and Pokhrel, S., Social sciences research in neglected tropical diseases 2: A bibliographic analysis. Health Research Policy and Systems, 2011. 9.
Pollitt, A., Wooding, S., Hanney, S., Buxton, M., and Grant, J., Project Retrosight: Understanding the returns from cardiovascular and stroke research: Case Studies. 2011: Santa Monica, CA.
Pollitt, A., Wooding, S., Hanney, S., Buxton, M., and Grant, J., Project Retrosight: Understanding the returns from cardiovascular and stroke research: Methodology Report. 2011: Santa Monica, CA. http://www.rand.org/pubs/technical_reports/TR925.html
Pokhrel, S., Reidpath, D., and Allotey, P., Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: A case study of Bill and Melinda Gates Foundation. Health Research Policy and Systems, 2011. 9.
Pavey, T.G., Taylor, A.H., Fox, K.R., Hillsdon, M., Anokye, N., Campbell, J.L., Foster, C., Green, C., Moxham, T., Mutrie, N., Searle, J., Trueman, P., and Taylor, R.S., Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ, 2011. 343.
Pavey, T.G., Anokye, N., Taylor, A.H., Trueman, P., Moxham, T., Fox, K.R., Hillsdon, M., Green, C., Campbell, J.L., Foster, C., Mutrie, N., Searle, J., and Taylor, R.S., The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technology Assessment, 2011. 15(44): p. 1-+.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, and Foster C, e.a., Exercise referral schemes in primary care: an effective approach to enhancing physical activity and improving health outcomes? British Medical Journal, 2011. 343.
Pavey T, Anokye N, Taylor A, Trueman P, Moxham T, and Fox KR, e.a., The Effectiveness and Cost-effectiveness of Exercise Referral Schemes: A Systematic Review and Economic Evaluation. Health Technology Assessment, 2011. 15(44).
Patel, S., Brown, S., Friede, T., Griffiths, F., Lord, J., Ngunjiri, A., Thistlethwaite, J., Tysall, C., Woolvine, M., and Underwood, M., Study protocol: Improving patient choice in treating low back pain (IMPACT - LBP): A randomised controlled trial of a decision support package for use in physical therapy. BMC Musculoskeletal Disorders, 2011. 12.
Ong, L.T.J., Storey, D., and Minnery, J., Beyond the Beach: Balancing Environmental and Socio-cultural Sustainability in Boracay, the Philippines. Tourism Geographies, 2011. 13(4): p. 549-569.
Olafsdottir, A.E., Reidpath, D.D., Pokhrel, S., and Allotey, P., Health systems performance in Sub-Saharan Africa: Governance, outcome and equity. BMC Public Health, 2011. 11.
Nason, E., Curran, B., Hanney, S., Janta, B., Hastings, G., O'Driscoll, M., and Wooding, S., Evaluating health research funding in Ireland: assessing the impacts of the Health Research Board of Ireland's funding activities. Research Evaluation, 2011. 20(3): p. 193-200.
Longworth, L., Sculpher, M.J., Bojke, L., and Tosh, J.C., Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence. International Journal of Technology Assessment in Health Care, 2011. 27(2): p. 180-187.
Latimer, N., Lord, J., Grant, R.L., O'Mahony, R., Dickson, J., and Conaghan, P.G., Value of information in the osteoarthritis setting: Cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors. PharmacoEconomics, 2011. 29(3): p. 225-237.
Klautzer, L., Hanney, S., Nason, E., Rubin, J., Grant, J., and Wooding, S., Assessing policy and practice impacts of social science research: the application of the Payback Framework to assess the Future of Work programme. Research Evaluation, 2011. 20(3): p. 201-209.
Hanney, S.R. and González-Block, M.A., Yes, research can inform health policy; but can we bridge the 'Do-Knowing It's Been Done' gap? Health Research Policy and Systems, 2011. 9. http://www.health-policy-systems.com/content/9/1/23
Hanney, S. and Griffiths, P., Ways of assessing the economic value or impact of research: Is it a step too far for nursing research? Journal of Research in Nursing, 2011. 16(2): p. 151-166.
Gillam, B., Palmisano, S.A., and Govan, D.G., Depth interval estimates from motion parallax and binocular disparity beyond interaction space. Perception, 2011. 40(1): p. 39-49.
Donovan, C. and Hanney, S., The 'Payback Framework' explained. Research Evaluation, 2011. 20(3): p. 181-183.
Donovan, C., State of the art in assessing research impact: introduction to a special issue. Research Evaluation, 2011. 20(3): p. 175-179.
Chalkidou, K., Lord, J., Obeidat, N.A., Alabbadi, I.A., Stanley, A.G., Bader, R., Momani, A., O'Mahony, R.M., Qatami, L., and Cutler, D., Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care. International Journal of Technology Assessment in Health Care, 2011. 27(2): p. 151-158.
Buxton, M.J. and Chambers, J.D., What values do the public want their health care systems to use in evaluating technologies? European Journal of Health Economics, 2011: p. 1-4.
Buxton, M., The payback of 'payback': Challenges in assessing research impact. Research Evaluation, 2011. 20(3): p. 259-260.
Bueno, H., Armstrong, P.W., Buxton, M.J., Danchin, N., Lubsen, J., Roland, E., Verheugt, F.W., Zalewski, A., Jackson, N., Komajda, M., and Steg, P.G., The future of clinical trials in secondary prevention after acute coronary syndromes. European Heart Journal, 2011. 32(13): p. 1583-1589.
Brazier, J., Rowen, D., Yang, Y., and Tsuchiya, A., Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale. European Journal of Health Economics, 2011: p. 1-13.
Brazier, J., Rowen, D., Tsuchiya, A., Yang, Y., and Young, T.A., The impact of adding an extra dimension to a preference-based measure. Social Science and Medicine, 2011. 73(2): p. 245-253.
Boehler, C.E.H., Lord, J., and Buxton, M.J., Mind the Gap! Geographic transferability of economic evaluation in health. HESG 2011.
Boehler, C.E., Milton, K.E., Bull, F.C., and Fox-Rushby, J.A., The cost of changing physical activity behaviour: Evidence from a "physical activity pathway" in the primary care setting. BMC Public Health, 2011. 11.
Berenguera, A., Pujol-Ribera, E., Rodriguez-Blanco, T., Violan, C., Casajuana, M., de Kort, N., and Trapero-Bertran, M., Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial. BMC Musculoskeletal Disorders, 2011. 12(1): p. 194.
Anokye, N.K., Trueman, P., Green, C., Pavey, T.G., Hillsdon, M., and Taylor, R.S., The cost-effectiveness of exercise referral schemes. BMC Public Health, 2011. 11.
Anokye, N.K., Pokhrel, S., Buxton, M., and Fox-Rushby, J., The demand for sports and exercise: results from an illustrative survey. European Journal of Health Economics, 2011: p. 1-11.
Acera, A., Rodriguez, A., Trapero-Bertran, M., Soteras, P., Sanchez, N., Bonet, J.M., Manresa, J.M., Hidalgo, P., Toran, P., and Prieto, G., Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial. BMC health services research, 2011. 11: p. 278
2010
Scoble R, Dickson K, Hanney S, Rodgers G. J. (2010) Institutional strategies for capturing socio-economic impact of academic research, Journal of Higher Education Policy and Management, 32: 5, 499— 510. To link to this Article: DOI: 10.1080/1360080X.2010.511122
http://dx.doi.org/10.1080/1360080X.2010.511122
Ling T, Soper B, Buxton M, Hanney S, Oortwijn W, Scoggins A, Steel N (2010) An Evaluation of The Health Foundation’s Engaging with Quality Initiative. London: The Health Foundation
Chambers JD, Neumann PJ, Buxton MJ (2010) Does Medicare have an implicit cost-effectiveness threshold? Medical Decision Making, doi: 10.1177/0272989X10371134
Dyer MT, Goldsmith KA, Sharples LD, Buxton MJ (2010) A review of health utilities using the EQ-5D in studies of cardiovascular disease, Health and Quality of Life Outcomes, vol 8 (13)
doi: 10.1186/1477-7525-8-13 http://www.hqlo.com/content/8/1/13
Goldsmith KA, Dyer MT, Buxton MJ, Sharples LD (2010) Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease, Health and Quality of Life Outcomes, vol 8 (54) doi: 10.1186/1477-7525-8-54
Lindgren P, Eriksson J, Buxton M, Kahan T, Poulter NR, Dahlof B, Sever PS, Wedel H, Jonsson B (2010) The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial, International Journal of Clinical Practice, Aug 2010;64(9):1228-1234, doi: 10.1111/j.1742-1241.2010.02445.x
Hanney SR, Kuruvilla S, Soper B, Mays N (2010) Who needs what from a national health research system: lessons from reforms to the English Department of Health’s R&D system, Health Research Policy and Systems, vol 8 (11) doi:10.1186/1478-4505-8-11
Brunetti M, Ruiz F, Lord J et al (2010) Grading economic evidence, Editors: Shemilt I, Mugford M, Vale L, Donaldson C, and Marsh K. Evidence-based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice, vol 10, pp 114-33. Oxford, John Wiley
doi: 10.1002/9781444320398
Pokhrel S, De Allegri M, Gbangou A, Sauerbourn R. (2010) Illness reporting and demand for medical care in rural Burkina Faso, Social Science and Medicine, vol 70 (11), pp 1693-700,
doi: 10.1016/j.socscimed.2010.02.002
Trueman P, Grainger DL, Downs KE (2010) Coverage with Evidence Development: Applications and issues, International Journal of Technology Assessment in Health Care, vol 26 (1), pp 79-85, doi: 10.1017/S0266462309990882
The Counterweight Project Team and P Trueman (2010) Long term cost-effectiveness of weight management in primary care, International Journal of Clinical Practice, vol 64(6), pp 775-783
Reeves D, Doran T, Valderas JM, Kontopantelis E, Trueman P, Sutton M, Campbell S, Lester H (2010) How to identify when a performance indicator has run its course, British Medical Journal vol 340, pp 899-901 doi:10.1136/bmj.c1717
Trueman P, Whitehead SJ (2010) The economics of pressure relieving surfaces: an illustrative case study of the impact of high-specification surfaces on hospital finances. Internal Wound Journal, vol 7(1), pp 48-54, doi: 10.1111/j.1742-481X.2009.00647.x
http://www.ncbi.nlm.nih.gov/pubmed/20409250
Beale S, Trueman P, Sanderson D, Kruger J (2010) The Initial Evaluation of the Scottish Telecare Development Program, Journal of Technology in Human Services, vol 28 (1), pp 60 – 73 doi: 10.1080/15228831003770767
Young T, Yang Y, Brazier J, Tsuchiya A (2010) The use of Rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D, Medical Decision Making, doi: 10.1177/0272989X10364846
Brazier J, Yang Y, Tsuchiya A, Rowen DL (2010) A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures, European Journal of Health Economics, vol 11 (2), pp 215 -5, DOI 10.1007/s10198-009-0168-z
2009
Appleby J, Devlin N, Parkin D, Buxton M, Chalkidou K (2009) Searching for cost effectiveness thresholds in the NHS, Health Policy, vol 91 (3), pp 239-45, doi: 10.1016/j.healthpol.2008.12.010
Lindgren P, Buxton M, Kahan T et al (2009) The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone. Results from ASCOT, Pharmacoeconomics, vol 27 (3), pp 221-30 doi: 10.2165/00019053-200927030-00005
Buxton MJ (2009) Screening for abdominal aortic aneurysm. Remains effective and is likely to be cost effective in the UK, but data need to be monitored (editorial), BMJ, vol 338, pp 1509-10 doi: 10.1136/bmj.b2243
Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M and Peto J on behalf of the ARTISTIC Trial Study Group (2009) ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening, Health Technol Assess, vol 13 (51) doi: 10.3310/hta13510
Clark A, Walker D, Mosqueira R, Penny M, Lanata C, Fox-Rushby J, Sanderson C (2009) Cost-effectiveness of Rotavirus vaccination in Peru, Journal of Infectious Diseases, vol 200, S114-24 doi: 10.1086/605043
Bennett P, Wilkinson C, Turner J, Edwards RT, France B, Griffith G, Gray J (2009) Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment, Familial Cancer, vol 8, pp 159-65
Raftery J, Hanney S, Green C, Buxton M (2009) Assessing the impact of England’s National Health Service R&D Health Technology Assessment program using the “payback” approach, International Journal of Technology Assessment in Health Care, vol 25 (1), pp1-5, doi: 10.1017/S0266462309090011
Hanney SR, González-Block MA (2009) Evidence-informed health policy: are we beginning to get there at last? Health Research Policy and Systems, vol 7 (30), doi: 10.1186/1478-4505-7-30
Wooding S, Nason E, Starkey T, Hanney S, Grant J (2009) Mapping the Impact: Exploring the Payback of Arthritis Research. Santa Monica CA: RAND Corporation
Marjanovic S, Hanney S, Wooding S (2009) A historical reflection on research evaluation studies, their recurrent themes and challenges. Santa Monica, CA: RAND
Latimer N, Lord J, Grant R et al (2009) Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis, BMJ, vol 339, b2538 doi: 10.1136/bmj.b2538
Mistry H, Dowie R, Franklin RCG and Jani BR (2009) Costs of neonatal care for low birthweight babies in English hospitals. Acta Paediatrica, doi:10.1111/j.1651-2227.2009.01316.x, http://www.cardiologymanagement.eu/downloads/CAR_V3_I1.pdf
Hidayat B, Pokhrel S (2009) The selection of an appropriate count data model for modeling health insurance and health care demand: case of Indonesia, International Journal of Environmental Research and Public Health, vol 7 (1), 9 – 27 doi:10.3390/ijerph7010009
Gnawali DP, Pokhrel S, Sié A et al (2009) The effect of community-based health insurance on the utilization of modern health care services: Evidence from Burkina Faso, Health Policy, vol 90 (2), pp 214-22 doi: 10.1016/j.healthpol.2008.09.015
Steuten L, Vallejo-Torres L, Bastide P, Buxton M (2009) Analysing uncertainty around costs of innovative medical technologies: The case of fibrin sealant (QUIXIL ®) for total knee replacement, Health Policy, vol 89, pp 46-57 doi:10.1016/j.healthpol.2008.05.002
Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R et al (2009) HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomized controlled trial, The Lancet Oncology, vol 10 (7), pp 672-82 doi: 10.1016/S1470-2045(09)70156-1
Trapero-Bertran M (2009) Economic evaluation of smoking cessation interventions: have we overlooked something? Arch Bronconeumol, vol 45 (5), pp 209-11, doi: 10.1016/j.arbres.2009.01.009
Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, Mas X, Trapero-Bertran M et al (2009) Cost-effectiveness of intermittent preventive treatment for malaria control in infants (IPTi) in Tanzania and Mozambique, Bulletin of World Health Organization, vol 87, pp 123-9
Young T, Yang Y, Brazier J, Tsuchiya A, Coyne K (2009) The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Quality of Life Research. vol 18 (2), pp 253-65, doi: 10.1007/s11136-008-9428-0
Yang Y, Brazier J, Tsuchiya A, Coyne K (2009) Estimating a preference-based single index from the Overactive Bladder Questionnaire, Value In Health, vol 12 (1), pp 159-66
2008
Jones T, Hanney S, Buxton M (2008) The role of the national general medical journal: surveys of which journals UK clinicians read to inform their clinical practice. Med Clin (Barc). 131(Supl 5):30-5
Buxton M, Hanney S (2008) Desarrollo y aplicación del Modelo Payback para la evaluación del impacto socioeconómico de la investigación en salud. Med Clin (Barc). 131(Supl 5): 36-41.
Hanney S, Gonzalez Block MA (2008) Evaluación del impacto de la investigación en la política sanitaria: conceptos y casos concretos. Med Clin (Barc). 131(Supl 5):81-6
Lindgren P, Buxton M, Kahan T et al (2008) Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost-effective compared to an atenolol-based regimen, Heart, vol 94
Henriksson M, Epstein DM, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, Henderson RA, Buxton M, Fox KAA (2008) The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial, Heart, vol 94, pp 717-23
Scott M, Price C, Cowie M, Buxton M (2008) Cost-consequences analysis of natriuretic peptide assays to refute symptomatic heart failure in primary care, The British Journal of Cardiology, vol 15, issue 4, pp 199-204
Claxton K, Briggs A, Buxton M, Culyer AJ, McCabe C, Walker S, Sculpher MJ (2008) Value based pricing for NHS drugs: an opportunity not to be missed? BMJ, vol 336, pp 251-4
Epstein D, Sculpher M, Clayton T, Henderson R, Pocock S, Buxton M, Fox K (2008) Costs of an early intervention versus a conservative strategy in acute coronary syndrome, International Journal of Cardiology, vol 127, pp 240-6
Epstein D, Sculpher M, Manca A, Michaels J, Thompson S, Brown L, Powell J, Buxton M, Greenhalgh R (2008) Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm, British Journal of Surgery, vol 95, no 2, pp 183-90
Buxton M, Hanney S, Morris S, Sundmacher L - Health Economics Research Group, Office of Health Economics, RAND Europe (2008) Medical Research - What's it worth? Estimating the economic benefits from medical research in the UK. London: UK Evaluation Forum
Milewa T, Buxton M and Hanney S (2008) Lay involvement in the public funding of medical research: expertise and counter-expertise in empirical and analytical perspective, Critical Public Health, vol 18 (3), pp 357-66
Dong H, Gbangou A, De Allegri M, Pokhrel S, Sauerborn R (2008) The differences in characteristics between health-care users and non-users: implication for introducing community-based health insurance in Burkina Faso, European Journal of Health Economics, vol 9, pp 41-50 doi 10.1007/s10198-006-0031-4
Dowie R, Mistry H, Young TA, Franklin RCG and Gardiner HM (2008) Cost implications of introducing a telecardiology service to support fetal ultrasound screening, Journal of Telemedicine and TeleCare, vol 14, pp 421-6
Dowie R, Mistry H, Rigby M et al (2008) A paediatric telecardiology service for district hospitals in south-east England: an observational study, Archives of Disease in Childhood http://adc.bmj.com/cgi/rapidpdf/adc.2008.138495v1
Dyer M, Goldsmith K, Khan S, Sharples L, Freeman C, Hardy I, Buxton M, Schofield P (2008) Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of Spinal Cord Stimulation (SCS) versus Percutaneous Myocardial Laser Revascularisation (PMR) in patients with Refractory Angina Pectoris: the SPiRiT trial, Trials http://www.trialsjournal.com/content/9/1/40
Castillo-Riquelme M, Chalabi Z, Lord J, Guhl F. Campbell-Lendrum D, Davies C, Fox-Rushby J (2008) Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: The example of Chagas disease, Journal of Health Economics, vol 27, pp 405-26
Onwujekwe O, Fox-Rushby J, Hanson K (2008) Construct validity of the bidding game, binary with follow-up and a novel structured haggling question format in determining willingness to pay for insecticide-treated mosquito nets, Medical Decision Making, vol 28, no 1, pp 90-101
Griffith GL, Morrison V, Williams JMG, Edwards RT (2008) Can we assume that research participants are utility maximizers? European Journal of Health Economics
Griffith GL , Edwards RT, Williams JMG et al (2008) Patient preferences and national health service costs: a cost-consequence analysis of cancer genetic services, Familial Cancer
Hanney S,Gonzalez Block MA (2008) Why national health research systems matter, Health Research Policy and Systems, vol 6, no 1 Doi: 10.1186/1478-4505-6-1
Nason E, Janta B, Hastings G, Hanney S, O'Driscoll M, Wooding S (2008) Health Researach - Making an Impact. The economic and social benefits of HRB-funded research. Dublin: Health Research Board. http://www.hrb.ie/uploads/tx_hrbpublications/Health_Reseach-Making_an_Impact.pdf
Oortwijn W, Hanney S, Ligtvoet A, Hoorens S, Wooding S, Grant J, Buxton M, Bouter L (2008) Assessing the impact of health technology assessment in the Netherlands, International Journal of Technology Assessment Health Care, vol 24, no 3, pp 259-69
Soper B, Buxton M, Hanney S et al (2008) Developing the protocol for the evaluation of the health Foundation's 'engaging with quality initiative': an emergent approach, Implementation Science, vol 3 (46) http://www.implementationscience.com/content/3/1/46
Steuten L, Vallejo-Torres L, Young T, Buxton M (2008) Transferability of economic evaluations of medical technologies: a new technology for orthopedic surgery, Expert Review of Medical Devices, vol 5, no 3, pp 329-36
Vallejo-Torres L, Steuten L, Buxton M et al (2008) Integrating Health Economics Moelling in the Product Development Cycle of Medical Devices: a Bayesian approach, International Journal of Technology Assessment in Health Care, vol 24 (4), pp 459-64
2007
Dong H, Coyle D, Buxton M (2007) Value of information analysis for a new technology: computer-assisted total knee replacement, International Journal of Technology Assessment in Health Care, vol 23, no 3, pp 337-42
Kim L, Thompson S, Briggs A, Buxton M, Campbell H (2007) How cost-effective is screening for abdominal aortic aneurysms, Journal of Medical Screening, vol 14, no 1, pp 46-52
Lindgren P, Kahan T, Poulter N, Buxton M, Svarvar P, Dahlof B, Johsson B on behalf of the ASCOT investigators (2007) Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy, European Journal of Health Economics, vol 8, pp 25-30 DOI: 10.1007/s10198-006-0002-9
Buxton M, Lacey L, Feagan B et al (2007) Mapping from disease-specific measures to utility: an analysis of the relationships between the inflammatory bowel disease questionnaire and Crohn's disease activity index in Crohn's disease and measures of utility, Value in Health, vol 10, no 3, pp 214-20 DOI: 10.1111/j.1524-4733.2007.00171.x
Griffin S, Barber J, Manca A, Sculpher M, Thompson S, Buxton M, Hemingway H (2007) Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective obervational study, BMJ, DOI:10.1136/bmj.39129.442164.55
Campbell H, Briggs H, Buxton M, Kim LG, Thompson SG (2007) The credibility of health economic decision analytic models for health policy making: the case of population screening for abdominal aortic aneurysm, Journal of Health Services Research and Policy, vol 12, no 1, pp 11-7
Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J (2007) Searching for a threshold, not setting one: the role of the National Institute of Health and Clinical Excellence, Journal of Health Services Research and Policy, vol 12, no 1, pp 56-8
Henriksson M, Epstein D, Palmer S, Sculpher M, Clayton T, Pocock S, Henderson R, Buxton M, Fox K (2007) The Cost-Effectiveness of an Early Interventional Strategy in Non-ST-Elevation Acute Coronary Syndrome Based on the RITA 3 Trial, Heart, DOI:10.1136/hrt.2007.127340
Buxton M (2007) Discussion of Paul Dolan and Aki Tsuchiya's paper: 'The measurement and valuation of public safety' in Mason A & Towse A (eds) pp 147-51 The Ideas and Influence of Alan Williams. Be Reasonable - Do It My Way, Radcliffe Publishing Ltd, UK
Dowie R, Mistry H, Young T et al (2007) Telemedicine in pediatric and perinatal cardiology: Economic evaluation of a service in English hospitals, International Journal of Technology Assessment in Health Care, vol 23, no 1, pp 116-25
Sharples L, Cafferty F, Demitis N, Freeman C, Dyer M, Banner N, Birks E, Khaghani A, Large S, Tsui S, Caine N, Buxton M (2007) Evaluation of the clinical effectiveness of the ventricular assist device progrm in the United Kingdom (EVAD UK), Journal of Heart and Lung Transplantation, vol 26, no 1, pp 9-15
Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K and Stone D (2007) Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess, 11(49) http://www.ncchta.org/project/1217.asp
Bennett P, Wilkinson C, Turner J, Griffith G, France B, Brain K and Gray J (2007) The impact of breast cancer genetic risk assessment on intentions to perform cancer surveillance behaviors. Journal of Genetic Counselling, vol 16, pp 617-23
Wooding S, Nason E, Klautzer L, Rubin J, Hanney S, Grant J (2007) Policy and practice impacts of research funded by the Economic and Social Research Council. A case study of the Future of Work programme, approach and analysis. Santa Monica, CA: RAND Corporation http://www.rand.org/pubs/technical_reports/TR435/
Soper B, Hanney S (2007) Lessons from the evaluation of the UK's NHS R&D Implementation Methods Programme, Implementation Science, 2:7 http://www.implementationscience.com/content/pdf/1748-5908-2-7.pdf
Hanney S, Buxton M, Green C, Coulson D, Raftery J (2007) An assessment of the impact of the NHS Health Technology Assessment Programme, Health Technol Assess, 11(53) http://www.ncchta.org/project/1440.asp
Jones T, Hanney S, Buxton M (2007) The information sources and journals consulted or read by UK paediatricians to inform their clinical practice and those which they consider important: a questionnaire survey, BMC Pediatrics, doi:10.1186/1471-2431-7-1 http://hdl.handle.net/2438/670
Mistry H, Dowie R, Young T, Gardiner M (on behalf of the TelePaed Project Team) (2007) Costs of NHS maternity care for women with multiple pregnancy compared with high-risk and low-risk singleton pregnancy, British Journal of Obstetrics and Gynaecology, vol 144, pp 1104-12
Aziz O, Rao C, Panesar S, Jones C, Morris S, Darzi A, Athanasiou T (2007) Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery, British Medical Journal, vol 334 (7594), pp 621 DOI: 10.1136/bmj.39106.476215.BE
Morris S, Ridley S, Munro V and Christensen M on behalf of the NovoSeven Trauma Study Group (2007) Cost effectiveness of recombinant activated factor VII for the control of bleeding in patients with severe blunt trauma injuries in the United Kingdom, Anaesthesia, vol 62, pp 43-52
Ridley S, Morris S (2007) The cost effectiveness of adult intensive care in the UK, Anaesthesia, vol 62, pp 547-54
Rao C, Aziz O, Panesar S, Jones C, Morris S, Darzi A, Athanasiou T (2007) Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery, British Medical Journal DOI: 10.1136/bmj.39112.480023.BE
Jeetley P, Burden L, Stoykova B, Senior R (2007) Clinical and economic impact of stress echocardiography compared to exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: A prospective randomized controlled study, Eur Heart J, 28: 204-211
Sabharval NK, Stoykova B, Taneja AK, Lahiri A (2007) A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: cost analysis, J Nucl Cardiol, Apr;14(2):174-86
2006
2005
Lindgren P, Buxton M, Kahan T et al (2005) Cost-effectiveness of atrovastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial - lipid-lowering arm (ASCOT-LLA), European Journal of Cardiovascular Prevention and Rehabilitation, vol 12, pp 29-36
Buxton M (as part of EVAR trial participants) (2005) Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. The Lancet, vol 365(9478), pp 2179-86
Buxton M (2005) How much are health-care systems prepared to pay to produce a QALY? The European Journal of Health Economics, vol 6, no 4, pp 285 (Editorial)
Ratcliffe J, Buxton M, Young T, Longworth L (2005) Determining priority for liver transplantation: a comparison of cost per QALY and discrete choice experiment generated public preferences, Applied Health Economics and Health Policy, vol 4, no 4, pp 249-55
Dong H, Kouyate B, Cairns J, Sauerborn R (2005) Inequality in willingness-to-pay for community-based health insurance, Health Policy, vol 72, pp 149-56
Khan MM, Khan SH, Walker D, Fox-Rushby J, Cutts F, Akramazzumam SM (2005) Cost of delivering child immunization services in urban Bangladesh: a study based on facility-level surveys, Journal of Health, Population & Nutrition, vol 22, no 4, pp 404-12
Fox-Rushby J, Johnson K, Mwanzo I, Allen T, Parker M (2005) Language and Culture: Moving between theory and practice in cross-cultural research in Revicki D and Lenderking W (eds) Advances in Health Outcomes Research Methods, Measurement, Statistical Analysis, and Clinical Applications, Kluwer, The Netherlands
Hanney S, Mugford M, Grant J, Buxton M (2005) Assessing the benefits of health research: lessons from research into the use of antenatal corticosteroids for the prevention of neonatal respiratory distress syndrome. Social Science & Medicine, vol 60, pp 937-47
Hanney SR, Home PD, Frame I, Grant J, Green P, Buxton MJ (2005) Identifying the impact of diabetes research, Diabetic Medicine. DOI:10.1111/j.1464-5491.2005.01753.x
Jones T, Hanney S, Buxton M, Rippon I (2005) Journals used for the publication of English psychiatry, surgery and paediatrics research, Aslib Proceedings, 57, no 3, pp 278-90
Longworth L, Buxton M, Sculpher M, Smith D (2005) Estimating utility data from clinical indicators for patients with stable angina. European Journal of Health Economics, vol 6, no 4, pp 288-97
Miners AH, Garau M, Fidan D, Fischer AJ (2005) Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study, BMJ, vol 330, pp 65-8
Mistry H, Buxton M, Longworth L, Chatwin J, Peveler R (2005) Comparison of GP records and patient self-report questionnaires for estimation of costs, European Journal of Health Economics, vol 6, no 3, pp 261-6
Stoykova B, Fox-Rushby J (2005) Use of Economic Evaluation in Practice and Policy in Fox-Rushby J, Cairns J (eds) Economic Evaluation in Health Care: an introductory guide to practice, McGraw Hill, pp 218-31
Ratcliffe J, Young T, Longworth L, Buxton M (2005) An assessment of the impact of informative drop out and nonresponse in measuring health related quality of life using the EuroQol ( EQ-5D) descriptive system, Value in Health, vol 8, no 1, pp 53-8
2004
Buxton M , Sullivan S, Andersson LF, Lamm CJ, Liljas B, Busse WW, Pedersen S, Weiss K (2004) County-specific cost-effectiveness of early intervention with budesonide in mild asthma, European Respiratory Journal , vol 24, pp 568-74
Bishop AJ, Marteau TM, Armstrong D, Chitty LS, Longworth L, Buxton M, Berlin C (2004) Women and health care professionals' preferences for Down's syndrome screening tests: A conjoint analysis study, British Journal of Obstetrics and Gynaecology, vol 111, pp 775-9
Weintraub WS, Mahoney EM, Zhang Z, Chu H, Hutton J, Buxton M et al (2004) One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial, Heart, vol 90 (7), pp 782-8
Briggs A, Buxton M, Drummond M, Goeree R, Sculpher M, Willan A (2004) Unfinished Symphony: A tribute to the life and career of Bernie O'Brien (1959-2004), Medical Decision Making, vol 24, pp 538-44
Ratcliffe J, Buxton M, McGarry T, Sheldon R, Chancellor J (2004) Patients' preferences for characteristics associated with treatments for osetoarthritis. Rheumatology, vol 43(3), pp 337-45
Buxton M (2004) The role of health economics in making recommendations to the NHS. In Rawlins M & Littlejohns P (eds) pp 185-7, Delivering Quality in the NHS 2004, Radcliffe Medical Press Ltd, Oxford
Mills A, Bennett S, Bloom G, Gonzalez-Block M, Pathmanathan I, Hanney S et al (2004) Getting Research to Policy and Practice. In: Strengthening health systems: the role and promise of health systems research, pp 51-70. Geneva: Alliance for Health Policy and Systems Research
Grant J, Hanney S, Buxton M (2004) Academic medicine: time for reinvention. Research needs researching (letter), BMJ, vol 328, p 48
Hanney S, Grant J, Wooding S, Buxton M (2004) Proposed methods for reviewing the outcomes of research: the impact of funding by the UK's Arthritis Reserach Campaign, Health Research Policy and Systems, vol 2 (4) http://hdl.handle.net/2438/675
Jones T, Hanney S, Buxton M, Burns T (2004) What British psychiatrists read. Questionnaire survey of journal usage among clinicians, British Journal of Psychiatry , vol 185, pp 251-7
Longworth L, Bryan S, Buxton M (2004) Reply to Koretz, Gastroenterology , vol 126, no 7, pp 1917
Miners AH , Garau M, Fidan D, Fischer AJ (2004) Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study, BMJ
Stoykova B, Dowie R , Kitchener HC, Assessing economics of treatments for gynaecological cancer where clinical effectiveness meets value for money (2004), International Journal of Gynecological Cancer , 14(5), 762-771
Stoykova B, Dowie R , Bastow P, Rowsell KV, Gregory RPF (2004) Ambulance emergency services for patients with coronary heart disease in Lancashire: achieving standards and improving performance, Emergency Medical Journal , vol 21, pp 99-104
Stoykova B, Dowie R, Gregory RPF, Rowsell KV, Lane S (2004) 'Event tree' approach for facilitating audit of ambulance cardiac services, Clinical Governance: An International Journal, vol 9, no 2, pp 115-22
Bryan S, Bungay HP, Weatherburn G, Field S (2004) Magnetic resonance imaging for investigation of the knee joint: a clinical and economic evaluation, International Journal of Technology Assessment in Health Care, vol 20 (2), pp 222-9
Young T, Thompson S (2004) The importance of accounting for the uncertainty of published prognostic model estimates, IJTAHC, vol 20 (4), pp 481-7




